TGFB1 and systemic sclerosis: Moreover, infiltratory B cells in the dermis of SSc patients produce pro-inflammatory and pro-fibrotic cytokines (e.g., IL-6), resulting in increased expression of TGF-β, which all together causes fibroblast activation and ECM deposition (e.g., collagen) in the sclerotic lesion [169].